Steven R. Hagen, Senior VP Pharmaceutical Development & Mfg at ALBANY MOLECULAR RESEARCH INC (AMRI), sold 2,500 shares at $15.19 ($38K) on 2014-02-25, disclosed to the SEC on 2014-02-25.
Open-market sale of $38k AMRI by Senior VP Pharmaceutical Development & Mfg. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AMRI | SELL | 2016-08-10 | $21K | — | Filing → |
| AMRI | SELL | 2016-05-16 | $30K | — | Filing → |
| AMRI | SELL | 2015-08-17 | $20K | — | Filing → |